178 related articles for article (PubMed ID: 33822352)
1. Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions.
Sławek J; Jost WH
Neurol Neurochir Pol; 2021; 55(2):125-132. PubMed ID: 33822352
[TBL] [Abstract][Full Text] [Related]
2. Cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin.
Szabó M; DO Kiem D; Gárdián G; Szpisjak L; Salamon A; Klivényi P; Zádori D
Ideggyogy Sz; 2023 Jan; 76(1-2):37-45. PubMed ID: 36892297
[TBL] [Abstract][Full Text] [Related]
4. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
6. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?
Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L
Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789
[TBL] [Abstract][Full Text] [Related]
7. Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification.
Pandey S; Kreisler A; Drużdż A; Biering-Sørensen B; Sławek J; Tatu L; Jost WH
Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():13. PubMed ID: 32775027
[TBL] [Abstract][Full Text] [Related]
8. Management of Anterocapitis and Anterocollis: A Novel Ultrasound Guided Approach Combined with Electromyography for Botulinum Toxin Injection of Longus Colli and Longus Capitis.
Farrell M; Karp BI; Kassavetis P; Berrigan W; Yonter S; Ehrlich D; Alter KE
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33008043
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
10. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
11. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review.
Erro R; Picillo M; Pellecchia MT; Barone P
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368692
[TBL] [Abstract][Full Text] [Related]
12. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia.
Allison SK; Odderson IR
Ultrasound Q; 2016 Sep; 32(3):302-6. PubMed ID: 26886108
[TBL] [Abstract][Full Text] [Related]
14. Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?
Kreisler A; Djelad S; Simonin C; Baille G; Mutez E; Degardin A; Defebvre L; Labreuche J; Cailliau E; Duhamel A
Rev Neurol (Paris); 2022 Jun; 178(6):591-602. PubMed ID: 34916042
[TBL] [Abstract][Full Text] [Related]
15. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
16. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses.
Bhidayasiri R
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S20-4. PubMed ID: 21999891
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
[TBL] [Abstract][Full Text] [Related]
18. A simplified ultrasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollis.
Walter U; Dudesek A; Fietzek UM
J Neural Transm (Vienna); 2018 Jul; 125(7):1037-1042. PubMed ID: 29488101
[TBL] [Abstract][Full Text] [Related]
19. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
[TBL] [Abstract][Full Text] [Related]
20. Cervical dystonia: clinical and therapeutic features in 85 patients.
Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
